Literature DB >> 2751984

Uveal melanoma management.

D H Char, E S Gragoudas, T L Phillips.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2751984      PMCID： PMC1041773          DOI： 10.1136/bjo.73.6.476

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  13 in total

1.  Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation.

Authors:  J M Seddon; E S Gragoudas; D M Albert; C C Hsieh; L Polivogianis; G R Friedenberg
Journal:  Am J Ophthalmol       Date:  1985-03-15       Impact factor: 5.258

2.  Long-term results of proton beam irradiated uveal melanomas.

Authors:  E S Gragoudas; J M Seddon; K Egan; R Glynn; J Munzenrider; M Austin-Seymour; M Goitein; L Verhey; M Urie; A Koehler
Journal:  Ophthalmology       Date:  1987-04       Impact factor: 12.079

3.  Histopathology of uveal melanomas treated with charged particle radiation.

Authors:  J B Crawford; D H Char
Journal:  Ophthalmology       Date:  1987-06       Impact factor: 12.079

4.  Choroidal melanoma growth patterns.

Authors:  D H Char; D C Heilbron; R P Juster; R D Stone
Journal:  Br J Ophthalmol       Date:  1983-09       Impact factor: 4.638

5.  Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body.

Authors:  J J Augsburger; J W Gamel; V F Sardi; R A Greenberg; J A Shields; L W Brady
Journal:  Arch Ophthalmol       Date:  1986-05

6.  Is irradiation a justifiable treatment of choroidal melanoma? Analysis of published results.

Authors:  W A Manschot; R Van Strik
Journal:  Br J Ophthalmol       Date:  1987-05       Impact factor: 4.638

7.  A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma.

Authors:  J M Seddon; D M Albert; P T Lavin; N Robinson
Journal:  Arch Ophthalmol       Date:  1983-12

8.  Growth rates and doubling times of posterior uveal melanomas.

Authors:  J J Augsburger; J R Gonder; J Amsel; J A Shields; L A Donoso
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

9.  Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis.

Authors:  I W McLean; W D Foster; L E Zimmerman
Journal:  Hum Pathol       Date:  1982-02       Impact factor: 3.466

10.  Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943--1952.

Authors:  O A Jensen
Journal:  Acta Ophthalmol (Copenh)       Date:  1982-04
View more
  1 in total

1.  A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib.

Authors:  A Maleka; G Åström; P Byström; G J Ullenhag
Journal:  BMC Cancer       Date:  2016-08-12       Impact factor: 4.430
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.